Christopher Jankowski

NPI: 1265114516
Total Payments
$1,272
2024 Payments
$1,201
Companies
12
Transactions
56

Payment Breakdown by Category

Food & Beverage$1,272 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,272 56 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $397.16 19 $0 (2024)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $375.23 10 $0 (2024)
Axsome Therapeutics, Inc. $163.71 10 $0 (2024)
Vanda Pharmaceuticals Inc. $78.92 3 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $64.23 2 $0 (2024)
Otsuka America Pharmaceutical, Inc. $49.93 3 $0 (2024)
Teva Pharmaceuticals USA, Inc. $35.85 2 $0 (2024)
IRONSHORE PHARMACEUTICALS INC. $32.12 2 $0 (2024)
Corium, LLC $22.48 2 $0 (2024)
Indivior Inc. $18.33 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,201 52 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($375.23)
2023 $70.64 4 ABBVIE INC. ($36.23)

All Payment Transactions

56 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.80 General
Category: NEUROSCIENCE
12/04/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $18.49 General
Category: SCHIZOPHRENIA
12/02/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $18.14 General
Category: Central Nervous System
11/26/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $26.94 General
Category: PSYCHIATRY
11/20/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.50 General
Category: NEUROSCIENCE
11/20/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $16.22 General
Category: Neuropsychiatry
11/13/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $15.53 General
Category: PSYCHIATRY
10/31/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $34.13 General
Category: SCHIZOPHRENIA
10/23/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $40.23 General
Category: NEUROSCIENCE
10/21/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $11.81 General
Category: Psychology/Psychiatric
10/21/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $5.58 General
Category: Psychology/Psychiatric
10/17/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $18.39 General
Category: PSYCHIATRY
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.42 General
Category: NEUROSCIENCE
09/25/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.83 General
Category: NEUROSCIENCE
09/24/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $13.95 General
Category: Psychology/Psychiatric
09/24/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $6.84 General
Category: Psychology/Psychiatric
09/11/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.68 General
Category: PSYCHIATRY
08/23/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.26 General
Category: NEUROSCIENCE
08/14/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.87 General
Category: NEUROSCIENCE
08/14/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.46 General
Category: NEUROSCIENCE
08/07/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $14.94 General
Category: PSYCHIATRY
08/01/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $26.30 General
Category: SCHIZOPHRENIA
07/30/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.93 General
Category: NEUROSCIENCE
07/25/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $10.46 General
Category: CNS Stimulant for ADHD
07/22/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.27 General
Category: NEUROSCIENCE

About Christopher Jankowski

Christopher Jankowski is a Psychiatric/Mental Health healthcare provider based in Ammon, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2023. The National Provider Identifier (NPI) number assigned to this provider is 1265114516.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Jankowski has received a total of $1,272 in payments from pharmaceutical and medical device companies, with $1,201 received in 2024. These payments were reported across 56 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,272).

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Ammon, ID
  • Active Since 08/07/2023
  • Last Updated 08/07/2023
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1265114516

Products in Payments

  • VRAYLAR (Drug) $377.12
  • CAPLYTA (Drug) $375.23
  • Auvelity (Drug) $163.71
  • FANAPT (Drug) $78.92
  • TRINTELLIX (Drug) $64.23
  • Austedo XR (Drug) $35.85
  • ABILIFY ASIMTUFII (Drug) $33.92
  • JORNAY PM (Drug) $32.12
  • Azstarys (Drug) $22.48
  • UBRELVY (Drug) $20.04
  • PERSERIS (Drug) $18.33
  • REXULTI (Drug) $17.60
  • INGREZZA (Drug) $16.22
  • ABILIFY MAINTENA (Drug) $16.01

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Ammon